When I think about feeling well, I picture energy, movement and enjoying ordinary life. That is why a review connecting weight treatment with muscle and sleep feels relevant to Her Own Way.
Pereira and colleagues look at semaglutide — the active ingredient in Ozempic and Wegovy — after menopause. They emphasise that losing some lean mass does not automatically mean muscle function has worsened.
What kind of evidence is this?
It is a short review that brings existing research together, not a new treatment trial. Advice on food and exercise specifically for postmenopausal women taking semaglutide still relies on indirect evidence.
We also do not yet have enough detail about semaglutide’s effects on their breathing problems during sleep.
For me, the review supports a broader conversation about nourishment and function while keeping those sleep questions open. It cannot turn every reasonable hope into a demonstrated benefit.